• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

Avella Recognized for 8th Consecutive Year on Inc. 5000 List

Posted by Avella Specialty Pharmacy on Tue, Sep 2, 2014
  • Tweet

Avella has once again been designated as one of Inc. Magazine’s 5,000 fastest growing companies in America, currently listed at #1,772 nationwide with a 3-year growth rate of 234%.  Avella has been included in this select group of innovative organizations since the magazine first started its annual list in 2006.

5000_color+stacked_mid“We are honored to be recognized alongside such an exclusive group of leading companies,” said Rebecca M. Shanahan, CEO of Avella. “Avella continues to build on the incredible growth we have experienced for nearly two decades. We attribute this success to our unwavering focus on clinical excellence as well as the premier, personalized service we provide to all of our customers.”

What does the Inc. 5000 recognition mean to Avella?  With our consistent growth over the years, this has allowed us to better serve our patient and provider customers.  As an innovator in the specialty pharmacy industry, we are always looking for ways to better patient health, whether it is through our new mobile app, 24/7 clinical pharmacist support, and dedicated treatment resources.  In addition, we strive to partner with our provider and payor customers to help improve medication adherence, provide better communication, and work with you as an extension of your team to manage your patient's needs.

How does Inc. determine this list?  Inc. identified companies for this year’s list by measuring growth from 2010 to 2013.  Companies must be US-based, privately held, for profit and independent (i.e. not subsidiaries or divisions of other companies) as of Dec. 31, 2013.  Avella met the publication’s rigorous criteria for inclusion in the 2014 list based on an average growth rate of 234% percent during this period.  

In addition, this is Avella's 8th consecutive year on the Inc. 5000 list.  We are honored to join the list with other companies in the healthcare industry who are also celebrating their 8th year on this exclusive list:

  • Novus Biologicals
  • Etransmedia Technology
  • Softwriters
  • eClinicalWorks
  • HealthHelp
  • Isagenix International
  • Health Advocate
  • Treo Solutions
  • BrightStar Care

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, visit http://www.inc.com/inc5000/list/2014. Read specific details about Avella’s listing.

Read More Avella News >>

Topics Avella Inc Inc 5000

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.